Dupilumab: tested in a combination
27 studies: another drug in the study is under test too. Page 1 of 1. Open to participants first (12), then studies with results posted, then the rest; newest registration first within each.
- Comparison of Eohilia With Dupixent on Esophagus Diameter in Patients With Eosinophilic Esophagitis.Enrolling by invitationNCT07358234Early Phase 1Report a problem
- A Study Assessing the Effect of Dupilumab on Inducing Clinical Remission in AsthmaRecruitingNCT07309614Phase 3Report a problem
- Neoadjuvant Dupilumab and Toripalimab in MSS CRC Subjects With Resectable Liver MetastasesRecruitingNCT07277322Phase 1/2Report a problem
- Tapering of Biologics in Chronic Rhinosinusitis With Nasal PolypsRecruitingNCT07187583Phase 4Report a problem
- Dupilumab Therapy in Nephrotic Syndrome in ChildrenRecruitingNCT07091175Phase 2Report a problem
- Biologics in Chronic Rhinosinusitis With Nasal PolyposisRecruitingNCT06824649Phase 4Report a problem
- Withdrawal of Dupilumab in Severe AsthmaRecruitingNCT06818019Phase 4Report a problem
- Study of Neoadjuvant Cemiplimab and Dupilumab in Early-Stage Non-Small Cell Lung CancerRecruitingNCT06743581Not applicableReport a problem
- Dupilumab Versus Topical Corticosteroid Effectiveness - Comparison in the Treatment of Stenotic EoERecruitingNCT06705387Phase 2Report a problem
- Leveraging Pharmacogenomics in Asthma for Predication, Mechanism and EndotypingRecruitingNCT06385236Phase 4Report a problem
- Neoadjuvant Dupilumab and Cemiplimab in Patients With Early-stage Resectable NSCLCRecruitingNCT06088771Phase 1/2Report a problem
- PD-1 +/- IL-4 Inhibition in ER+ Breast CancerNot yet recruitingNCT05967884Phase 2Report a problem
- Longitudinal Endotyping Of Atopic Dermatitis Through Transcriptomic Skin AnalysisCompletedNCT05436535Phase 4Results postedReport a problem
- EValuating trEatment RESponses of Dupilumab Versus Omalizumab in Type 2 PatientsCompletedNCT04998604Phase 4Results postedReport a problem
- Grass Pollen Immunotherapy Plus Dupilumab for Tolerance InductionCompletedNCT04502966Phase 2Results postedReport a problem
- Efficacy and Safety of REGN3500 Monotherapy and Combination of REGN3500 Plus Dupilumab in Adult Patients With Moderate-to-Severe Atopic DermatitisTerminatedNCT03736967Phase 2Results postedReport a problem
- Clinical Study Using Biologics to Improve Multi OIT Outcomes (COMBINE)CompletedNCT03679676Phase 2Results postedReport a problem
- Dupilumab As An Adjunct For Subcutaneous Grass ImmunotherapyCompletedNCT03558997Phase 2Results postedReport a problem
- Dupilumab and House Dust Mite Immunotherapy in Patients With Atopic DermatitisCompletedNCT06509243Not applicableReport a problem
- A Real-world, Head-to-head Comparison of Dupilumab Versus Mepolizumab in Danish Patients With Chronic Rhinosinusitis With Nasal PolypsActive, not recruitingNCT05942222Phase 4Report a problem
- Dupilumab Step-down Strategy to Maintain Remission in Adult and Adolescents Patients With Atopic DermatitisCompletedNCT05642208Phase 4Report a problem
- Dupilumab_Metastatic NSCLCActive, not recruitingNCT05013450Phase 1/2Report a problem
- Scientific Substantiation and Assessment of the Effectiveness of Pathogenetic Methods of Therapy for Congenital Ichthyosis in ChildrenStatus unknownNCT04996485Phase 4Report a problem
- Evaluation of the Effectiveness and Safety of Immunosuppressive and Biological Therapy of Atopic Dermatitis in ChildhoodStatus unknownNCT04895423Phase 4Report a problem
- NMF-CsA-Dupi TrialStatus unknownNCT04878770Not applicableReport a problem
- A Pilot Study of the Efficacy and Safety of Dupilumab Versus Placebo in Patients With Netherton SyndromeTerminatedNCT04244006Phase 2/3Report a problem
- Study of REGN3500 and Dupilumab in Patients With AsthmaCompletedNCT03112577Phase 1Report a problem